What does CUSIP 28176E108 represent in this 13F holders report?

CUSIP 28176E108 is the security identifier for EW - Edwards Lifesciences Corp - Common Stock used to aggregate holder disclosures.

How many institutions held EW - Edwards Lifesciences Corp - Common Stock in Q2 2025?

1244 institutional investors reported EW - Edwards Lifesciences Corp - Common Stock for Q2 2025. Use the holders table for investor-level position and value details.

Edwards Lifesciences Corp - Common Stock (EW)

CUSIP: 28176E108

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock
Total 13F shares: 501,621,113
Total 13F value: $39,209,886,931
Share change: +4,233,269
Put/Call ratio: 52%
SEC-reported price per share: $78.21
Number of holders: 1,244
Value change: +$342,426,537
Number of buys: 561
Number of sells: 550
Shares outstanding: 576,625,106

Security key

28176E108

Report period

Q2 2025

Institutions

1,244

Top holders

EW full security history Ownership snapshot Full 13F holder table Edwards Lifesciences Corp SEC filings Edwards Lifesciences Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of EW - Edwards Lifesciences Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

WELLINGTON MANAGEMENT GRO...

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Mar 2025

13F 13D/G Lead comparable stake: 3.4% 13D/G row: WELLINGTON MANAGEMENT GROUP LLP Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 3.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.

Comparable ownership Top 5

WELLINGTON MANAGEMENT GROUP LLP 3.4%

VANGUARD GROUP INC 12%

BlackRock, Inc. 9.5%

STATE STREET CORP 4.5%

JPMORGAN CHASE & CO 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F 13D/G Company 13F 13D/G	3.4% from 13D/G	$2,111,689,577 29,134,790 shares	—	31 Mar 2025
VANGUARD GROUP INC	13F Company 13F	12%	$5,015,531,054 69,198,828 shares	—	31 Mar 2025
BlackRock, Inc.	13F Company 13F	9.5%	$3,965,496,253 54,711,593 shares	—	31 Mar 2025
STATE STREET CORP	13F Company 13F	4.5%	$1,868,785,326 25,783,462 shares	—	31 Mar 2025
JPMORGAN CHASE & CO	13F Company 13F	3.8%	$1,591,803,383 21,961,966 shares	—	31 Mar 2025
Bank of New York Mellon Corp	13F Company 13F	3.1%	$1,279,716,879 17,656,138 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,244

501,621,113

Rows available

1,244

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

1,190

Q2 2025 holders

1,244

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %